Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase

. 1969 Mar;23(1):141–149. doi: 10.1038/bjc.1969.21

Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.

PMCID: PMC2008319 PMID: 5768430

These references are in PubMed. This may not be the complete list of references from this article.

Currie G. A. Masking of antigens on the Landschütz ascites tumour. Lancet. 1967 Dec 23;2(7530):1336–1338. doi: 10.1016/s0140-6736(67)90918-x. [DOI] [PubMed] [Google Scholar]
KLEIN G., SJOGREN H. O., KLEIN E., HELLSTROM K. E. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res. 1960 Dec;20:1561–1572. [PubMed] [Google Scholar]
PREHN R. T., MAIN J. M. Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst. 1957 Jun;18(6):769–778. [PubMed] [Google Scholar]
Sanford B. H. An alteration in tumor histocompatibility induced by neuraminidase. Transplantation. 1967 Sep 5;5(5):1273–1279. doi: 10.1097/00007890-196709000-00005. [DOI] [PubMed] [Google Scholar]